Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.
Although current malaria therapies inhibit pathways encoded in the parasite's genome, we have looked for anti-malaria drugs that can target an erythrocyte component because development of drug resistance might be suppressed if the parasite cannot mutate the drug's target. In search for suc...
Main Authors: | Kristina Kesely, Panae Noomuna, Michal Vieth, Philip Hipskind, Kasturi Haldar, Antonella Pantaleo, Francesco Turrini, Philip S Low |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0242372 |
Similar Items
-
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia.
by: Kristina R Kesely, et al.
Published: (2016-01-01) -
VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
by: Eduard Rovira-Vallbona, et al.
Published: (2013-01-01) -
Influence of Malaria Parasitemia of Plasmodium Falciparum on the Prevalence and Severity of Premenstrual Syndrome
by: Chigozie Ozoemena Ifeadike, et al.
Published: (2017-11-01) -
A validation study of microscopy versus quantitative PCR for measuring Plasmodium falciparum parasitemia
by: Emma Ballard, et al.
Published: (2019-08-01) -
The Role of Calcium and Glucose on the Increasing of Parasitemia Value and Hemolysis into Plasmodium falciparum-infected Erythrocyte
by: Verry Asfirizal
Published: (2016-04-01)